Literature DB >> 12417760

Antiepileptic drugs and apoptotic neurodegeneration in the developing brain.

Petra Bittigau1, Marco Sifringer, Kerstin Genz, Ellen Reith, Dana Pospischil, Suresh Govindarajalu, Mark Dzietko, Stefanie Pesditschek, Ingrid Mai, Krikor Dikranian, John W Olney, Chrysanthy Ikonomidou.   

Abstract

Epilepsy is the most common neurological disorder of young humans. Each year 150,000 children in the United States experience their first seizure. Antiepileptic drugs (AEDs), used to treat seizures in children, infants, and pregnant women, cause cognitive impairment, microcephaly, and birth defects. The cause of unwanted effects of therapy with AEDs is unknown. Here we reveal that phenytoin, phenobarbital, diazepam, clonazepam, vigabatrin, and valproate cause apoptotic neurodegeneration in the developing rat brain at plasma concentrations relevant for seizure control in humans. Neuronal death is associated with reduced expression of neurotrophins and decreased concentrations of survival-promoting proteins in the brain. beta-Estradiol, which stimulates pathways that are activated by neurotrophins, ameliorates AED-induced apoptotic neurodegeneration. Our findings present one possible mechanism to explain cognitive impairment and reduced brain mass associated with prenatal or postnatal exposure of humans to antiepileptic therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417760      PMCID: PMC137548          DOI: 10.1073/pnas.222550499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  The biochemistry of apoptosis.

Authors:  M O Hengartner
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

Review 2.  Neurotrophins: roles in neuronal development and function.

Authors:  E J Huang; L F Reichardt
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

Review 3.  Neuroprotective activities of estrogen: an update.

Authors:  C Behl; D Manthey
Journal:  J Neurocytol       Date:  2000 May-Jun

Review 4.  Vigabatrin: a novel therapy for seizure disorders.

Authors:  B E Gidal; M D Privitera; R D Sheth; J T Gilman
Journal:  Ann Pharmacother       Date:  1999-12       Impact factor: 3.154

5.  Association of prenatal phenobarbital and phenytoin exposure with small head size at birth and with learning problems.

Authors:  A B Dessens; P T Cohen-Kettenis; G J Mellenbergh; J G Koppe; N E van De Poll; K Boer
Journal:  Acta Paediatr       Date:  2000-05       Impact factor: 2.299

Review 6.  The replacement of oestradiol and progesterone in very premature infants.

Authors:  A Trotter; F Pohlandt
Journal:  Ann Med       Date:  2000-12       Impact factor: 4.709

7.  BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway.

Authors:  B H Han; D M Holtzman
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

8.  Does perinatal phenobarbital exposure affect developmental outcome at age 2?

Authors:  J A Thorp; M O'Connor; A M Jones; E L Hoffman; B Belden
Journal:  Am J Perinatol       Date:  1999       Impact factor: 1.862

9.  The teratogenicity of anticonvulsant drugs.

Authors:  L B Holmes; E A Harvey; B A Coull; K B Huntington; S Khoshbin; A M Hayes; L M Ryan
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245

Review 10.  A new concept in neurodegeneration: TNFalpha is a silencer of survival signals.

Authors:  H D Venters; R Dantzer; K W Kelley
Journal:  Trends Neurosci       Date:  2000-04       Impact factor: 13.837

View more
  215 in total

Review 1.  Pharmacotherapy for Seizures in Neonates with Hypoxic Ischemic Encephalopathy.

Authors:  Elissa Yozawitz; Arthur Stacey; Ronit M Pressler
Journal:  Paediatr Drugs       Date:  2017-12       Impact factor: 3.022

2.  Decreased serum BDNF levels in patients with epileptic and psychogenic nonepileptic seizures.

Authors:  W C LaFrance; K Leaver; E G Stopa; G D Papandonatos; A S Blum
Journal:  Neurology       Date:  2010-10-05       Impact factor: 9.910

Review 3.  NMDA receptors and metaplasticity: mechanisms and possible roles in neuropsychiatric disorders.

Authors:  Charles F Zorumski; Yukitoshi Izumi
Journal:  Neurosci Biobehav Rev       Date:  2012-01-02       Impact factor: 8.989

4.  Prenatal effects of antiepileptic drugs.

Authors:  Chrysanthy Ikonomidou
Journal:  Epilepsy Curr       Date:  2010-03       Impact factor: 7.500

5.  A novel approach to the study of hypoxia-ischemia-induced clinical and subclinical seizures in the neonatal rat.

Authors:  M Cuaycong; M Engel; S L Weinstein; E Salmon; J M Perlman; S Sunderam; S J Vannucci
Journal:  Dev Neurosci       Date:  2011-09-27       Impact factor: 2.984

Review 6.  Cognitive/behavioral teratogenetic effects of antiepileptic drugs.

Authors:  Kimford J Meador; Gus Baker; Morris J Cohen; Eija Gaily; Michael Westerveld
Journal:  Epilepsy Behav       Date:  2007-11       Impact factor: 2.937

Review 7.  Neonatal seizures: advances in mechanisms and management.

Authors:  Hannah C Glass
Journal:  Clin Perinatol       Date:  2013-12-12       Impact factor: 3.430

8.  Neuroprotective effect of levetiracetam on hypoxic ischemic brain injury in neonatal rats.

Authors:  Mustafa Komur; Cetin Okuyaz; Yalcin Celik; Bora Resitoglu; Ayse Polat; Senay Balci; Lulufer Tamer; Semra Erdogan; Huseyin Beydagi
Journal:  Childs Nerv Syst       Date:  2014-02-14       Impact factor: 1.475

9.  Using animal models to evaluate the functional consequences of anesthesia during early neurodevelopment.

Authors:  Susan E Maloney; Catherine E Creeley; Richard E Hartman; Carla M Yuede; Charles F Zorumski; Vesna Jevtovic-Todorovic; Krikor Dikranian; Kevin K Noguchi; Nuri B Farber; David F Wozniak
Journal:  Neurobiol Learn Mem       Date:  2018-03-14       Impact factor: 2.877

10.  Epilepsy: Neonatal seizures still lack safe and effective treatment.

Authors:  Marianne Thoresen; Hemmen Sabir
Journal:  Nat Rev Neurol       Date:  2015-04-28       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.